No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d1lcpA1, 1.0000, 0.00, 1.000, 159, 159, BOVINE LENS LEUCINE AMINOPEPTIDASE COMPLEXED WITH L-LEUCINE PHOSPHONIC ACID
2, d1lamA2, 0.9985, 0.18, 1.000, 159, 159, LEUCINE AMINOPEPTIDASE (UNLIGATED)
3, d1lcpB1, 0.9978, 0.18, 1.000, 159, 159, BOVINE LENS LEUCINE AMINOPEPTIDASE COMPLEXED WITH L-LEUCINE PHOSPHONIC ACID
4, d1lanA1, 0.9971, 0.22, 1.000, 159, 159, LEUCINE AMINOPEPTIDASE COMPLEX WITH L-LEUCINAL
5, d2j9aA2, 0.9954, 0.26, 1.000, 159, 159, BLLAP IN COMPLEX WITH MICROGININ FR1
6, d2ewbA2, 0.9951, 0.35, 1.000, 159, 159, THE CRYSTAL STRUCTURE OF BOVINE LENS LEUCINE AMINOPEPTIDASE IN COMPLEX WITH ZOFENOPRILAT
7, d1lapA2, 0.9730, 0.33, 1.000, 159, 159, MOLECULAR STRUCTURE OF LEUCINE AMINOPEPTIDASE AT 2.7-ANGSTROMS RESOLUTION
8, d1bllE1, 0.9728, 0.44, 1.000, 156, 156, X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE STRUCTURE OF BOVINE LENS LEUCINE AMINOPEPTIDASE COMPLEXED WITH AMASTATIN: FORMULATION OF A CATALYTIC MECHANISM FEATURING A GEM-DIOLATE TRANSITION STATE
9, d1bpnA2, 0.9701, 0.47, 1.000, 156, 156, DIFFERENTIATION AND IDENTIFICATION OF THE TWO CATALYTIC METAL BINDING SITES IN BOVINE LENS LEUCINE AMINOPEPTIDASE BY X-RAY CRYSTALLOGRAPHY
10, d1bpmA2, 0.9689, 0.53, 1.000, 156, 156, DIFFERENTIATION AND IDENTIFICATION OF THE TWO CATALYTIC METAL BINDING SITES IN BOVINE LENS LEUCINE AMINOPEPTIDASE BY X-RAY CRYSTALLOGRAPHY
11, p3h8fE1, 0.7403, 0.56, 1.000, 156, 156, HIGH PH NATIVE STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
12, p3h8fF1, 0.7361, 2.47, 0.196, 177, 143, HIGH PH NATIVE STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
13, d3vfqA1, 0.7358, 2.57, 0.187, 177, 144, HUMAN PARP14 (ARTD8 BAL2) - MACRO DOMAINS 1 AND 2 IN COMPLEX WITH ADENOSINE-5-DIPHOSPHORIBOSE
14, p3h8gD1, 0.7358, 2.63, 0.097, 184, 144, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
15, p3h8fC1, 0.7354, 2.61, 0.181, 177, 144, HIGH PH NATIVE STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
16, d4d86A1, 0.7353, 2.54, 0.182, 177, 143, HUMAN PARP14 (ARTD8 BAL2) - MACRO DOMAINS 1 AND 2 IN COMPLEX WITH ADENOSINE-5-DIPHOSPHATE
17, p3h8gA1, 0.7344, 2.55, 0.112, 184, 143, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
18, p3h8gF1, 0.7343, 2.62, 0.181, 177, 144, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
19, p3h8gC1, 0.7340, 2.63, 0.181, 177, 144, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
20, p3h8fA1, 0.7335, 2.61, 0.194, 177, 144, HIGH PH NATIVE STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
21, p3h8gE1, 0.7333, 2.55, 0.196, 177, 143, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
22, p3h8fD1, 0.7331, 2.55, 0.196, 177, 143, HIGH PH NATIVE STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
23, p3h8gB1, 0.7329, 2.63, 0.181, 177, 144, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
24, p3h8eB1, 0.7324, 2.60, 0.187, 177, 144, LOW PH NATIVE STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
25, p3h8fB1, 0.7323, 2.63, 0.194, 177, 144, HIGH PH NATIVE STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
26, p3h8eA1, 0.7319, 2.68, 0.181, 174, 144, LOW PH NATIVE STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM PSEUDOMONAS PUTIDA
27, p3q6zA_, 0.7305, 2.55, 0.196, 177, 143, HUMAN PARP14 (ARTD8)-MACRO DOMAIN 1 IN COMPLEX WITH ADENOSINE-5- DIPHOSPHORIBOSE
28, p3jruA1, 0.7238, 2.70, 0.181, 174, 144, CRYSTAL STRUCTURE OF LEUCYL AMINOPEPTIDASE (PEPA) FROM XOO0834 XANTHOMONAS ORYZAE PV. ORYZAE KACC10331
29, p3jruB1, 0.7223, 2.62, 0.105, 185, 143, CRYSTAL STRUCTURE OF LEUCYL AMINOPEPTIDASE (PEPA) FROM XOO0834 XANTHOMONAS ORYZAE PV. ORYZAE KACC10331
30, d5lccB1, 0.7173, 2.62, 0.105, 185, 143, OCEANOBACILLUS IHEYENSIS MACRODOMAIN MUTANT D40A
31, d1zr3A_, 0.7117, 2.58, 0.176, 173, 142, CRYSTAL STRUCTURE OF THE MACRO-DOMAIN OF HUMAN CORE HISTONE VARIANT MACROH2A1.1 (FORM B)
32, d1gytL1, 0.7113, 2.58, 0.176, 173, 142, E. COLI AMINOPEPTIDASE A (PEPA)
33, d5cb3A_, 0.7109, 2.69, 0.183, 173, 142, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
34, d1gytC1, 0.7109, 2.58, 0.121, 185, 140, E. COLI AMINOPEPTIDASE A (PEPA)
35, d5cmsQ_, 0.7106, 2.66, 0.106, 186, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
36, d5cmsJ_, 0.7098, 2.88, 0.111, 178, 144, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
37, d1gytB1, 0.7098, 2.76, 0.092, 171, 141, E. COLI AMINOPEPTIDASE A (PEPA)
38, d5cmsO_, 0.7096, 2.89, 0.111, 178, 144, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
39, d5cmsF_, 0.7096, 2.75, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
40, d5cmsD_, 0.7096, 2.75, 0.092, 172, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
41, d5cmsP_, 0.7095, 2.88, 0.111, 178, 144, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
42, d5cmsN_, 0.7093, 2.75, 0.092, 172, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
43, d1gytF1, 0.7093, 2.75, 0.092, 172, 141, E. COLI AMINOPEPTIDASE A (PEPA)
44, d1gytD1, 0.7093, 2.75, 0.092, 173, 141, E. COLI AMINOPEPTIDASE A (PEPA)
45, d5cmsM_, 0.7091, 2.75, 0.092, 172, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
46, d5cmsH_, 0.7091, 2.75, 0.092, 171, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
47, d1gytE1, 0.7091, 2.86, 0.111, 178, 144, E. COLI AMINOPEPTIDASE A (PEPA)
48, d5cmsR_, 0.7087, 2.89, 0.111, 178, 144, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
49, d5cmsK_, 0.7086, 2.76, 0.092, 172, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
50, d1gytH1, 0.7086, 2.76, 0.092, 172, 141, E. COLI AMINOPEPTIDASE A (PEPA)
51, d5cmsB_, 0.7085, 2.88, 0.111, 178, 144, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
52, d1zr3C_, 0.7085, 2.76, 0.092, 172, 141, CRYSTAL STRUCTURE OF THE MACRO-DOMAIN OF HUMAN CORE HISTONE VARIANT MACROH2A1.1 (FORM B)
53, d5cmsG_, 0.7084, 2.76, 0.092, 171, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
54, d5cmsL_, 0.7083, 2.89, 0.111, 178, 144, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
55, d5cmsC_, 0.7083, 2.76, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
56, d5cb5J_, 0.7083, 2.69, 0.099, 184, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
57, d5cmsI_, 0.7082, 2.76, 0.092, 171, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
58, d5cmsA_, 0.7082, 2.77, 0.092, 171, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
59, d5cb5L_, 0.7082, 2.77, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
60, d5cmsE_, 0.7081, 2.78, 0.092, 172, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
61, d5cb5H_, 0.7081, 2.77, 0.092, 171, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
62, d5cb5P_, 0.7080, 2.77, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
63, d5cb5O_, 0.7080, 2.76, 0.092, 172, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
64, d5cb5N_, 0.7080, 2.77, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
65, d5cb5K_, 0.7080, 2.77, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
66, d5lccA1, 0.7079, 2.77, 0.092, 173, 141, OCEANOBACILLUS IHEYENSIS MACRODOMAIN MUTANT D40A
67, d5cb5F_, 0.7078, 2.77, 0.092, 171, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
68, d5cb5R_, 0.7076, 2.77, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
69, d5cb5I_, 0.7075, 2.77, 0.092, 172, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
70, d5cb5G_, 0.7075, 2.68, 0.121, 185, 140, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
71, d5cb5A_, 0.7075, 2.77, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
72, d5cb5M_, 0.7073, 2.78, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
73, d5cb5B_, 0.7073, 2.78, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
74, d1gytA1, 0.7073, 2.78, 0.092, 173, 141, E. COLI AMINOPEPTIDASE A (PEPA)
75, d5fudA1, 0.7072, 2.77, 0.092, 173, 141, OCEANOBACILLUS IHEYENSIS MACRODOMAIN WITH MES BOUND
76, d5cb5Q_, 0.7072, 2.77, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
77, d5cb5E_, 0.7068, 2.78, 0.092, 173, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
78, d5cb5C_, 0.7068, 2.78, 0.092, 172, 141, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
79, d3q71A1, 0.7068, 2.93, 0.111, 178, 144, HUMAN PARP14 (ARTD8) - MACRO DOMAIN 2 IN COMPLEX WITH ADENOSINE-5- DIPHOSPHORIBOSE
80, d1gytI1, 0.7065, 2.93, 0.111, 178, 144, E. COLI AMINOPEPTIDASE A (PEPA)
81, d1gytG1, 0.7064, 2.76, 0.121, 185, 140, E. COLI AMINOPEPTIDASE A (PEPA)
82, d1yd9C2, 0.7063, 2.76, 0.121, 185, 140, 1.6A CRYSTAL STRUCTURE OF THE NON-HISTONE DOMAIN OF THE HISTONE VARIANT MACROH2A1.1.
83, d1spvA_, 0.7061, 2.79, 0.092, 173, 141, CRYSTAL STRUCTURE OF THE PUTATIVE PHOSPHATASE OF ESCHERICHIA COLI NORTHEAST STRUCTURAL GENOMOICS TARGET ER58
84, d1gytJ1, 0.7059, 2.79, 0.092, 173, 141, E. COLI AMINOPEPTIDASE A (PEPA)
85, d4d86A2, 0.7056, 2.79, 0.092, 173, 141, HUMAN PARP14 (ARTD8 BAL2) - MACRO DOMAINS 1 AND 2 IN COMPLEX WITH ADENOSINE-5-DIPHOSPHATE
86, d5fudB1, 0.7054, 2.99, 0.090, 193, 144, OCEANOBACILLUS IHEYENSIS MACRODOMAIN WITH MES BOUND
87, d5lauA1, 0.7051, 2.99, 0.090, 193, 144, OCEANOBACILLUS IHEYENSIS MACRODOMAIN MUTANT G37V WITH ADPR
88, p5iitD3, 0.7050, 2.91, 0.111, 178, 144, STRUCTURE OF SPX DOMAIN OF THE YEAST INORGANIC POLYPHOPHATE POLYMERASE VTC4 CRYSTALLIZED BY CARRIER-DRIVEN CRYSTALLIZATION IN FUSION WITH THE MACRO DOMAIN OF HUMAN HISTONE MACROH2A1.1
89, d5lbpA1, 0.7049, 2.91, 0.111, 178, 144, OCEANOBACILLUS IHEYENSIS MACRODOMAIN MUTANT N30A
90, d3vfqA2, 0.7049, 2.70, 0.099, 186, 141, HUMAN PARP14 (ARTD8 BAL2) - MACRO DOMAINS 1 AND 2 IN COMPLEX WITH ADENOSINE-5-DIPHOSPHORIBOSE
91, d2bfrA_, 0.7048, 2.70, 0.093, 171, 140, THE MACRO DOMAIN IS AN ADP-RIBOSE BINDING MODULE
92, d1hjzB_, 0.7044, 2.95, 0.111, 178, 144, CRYSTAL STRUCTURE OF AF1521 PROTEIN CONTAINING A MACROH2A DOMAIN
93, d1hjzA_, 0.7044, 3.01, 0.090, 177, 144, CRYSTAL STRUCTURE OF AF1521 PROTEIN CONTAINING A MACROH2A DOMAIN
94, d1gytK1, 0.7044, 2.76, 0.121, 185, 140, E. COLI AMINOPEPTIDASE A (PEPA)
95, p5kivA_, 0.7041, 2.72, 0.121, 184, 140, CRYSTAL STRUCTURE OF SAUMACRO (SAV0325)
96, d5l9qB1, 0.7039, 2.71, 0.113, 185, 141, OCEANOBACILLUS IHEYENSIS MACRODOMAIN WITH ADP
97, d5l9qA1, 0.7039, 2.75, 0.121, 185, 140, OCEANOBACILLUS IHEYENSIS MACRODOMAIN WITH ADP
98, d5cb5D_, 0.7033, 3.01, 0.090, 177, 144, STRUCTURAL INSIGHTS INTO THE MECHANISM OF ESCHERICHIA COLI YMDB
99, d5l9kA1, 0.7029, 2.87, 0.128, 191, 141, OCEANOBACILLUS IHEYENSIS MACRODOMAIN WITH ADPR
100, d5l9kB1, 0.7026, 2.84, 0.128, 192, 141, OCEANOBACILLUS IHEYENSIS MACRODOMAIN WITH ADPR
101, d1yd9A1, 0.6999, 2.83, 0.135, 192, 141, 1.6A CRYSTAL STRUCTURE OF THE NON-HISTONE DOMAIN OF THE HISTONE VARIANT MACROH2A1.1.
102, p5lncA3, 0.6998, 2.83, 0.135, 192, 141, STRUCTURE OF SPX DOMAIN OF THE YEAST INORGANIC POLYPHOPHATE POLYMERASE VTC4 CRYSTALLIZED BY CARRIER-DRIVEN CRYSTALLIZATION IN FUSION WITH THE MACRO DOMAIN OF HUMAN HISTONE MACROH2A1.1
103, p5iitB3, 0.6989, 2.94, 0.111, 178, 144, STRUCTURE OF SPX DOMAIN OF THE YEAST INORGANIC POLYPHOPHATE POLYMERASE VTC4 CRYSTALLIZED BY CARRIER-DRIVEN CRYSTALLIZATION IN FUSION WITH THE MACRO DOMAIN OF HUMAN HISTONE MACROH2A1.1
104, d2bfqA_, 0.6980, 2.99, 0.084, 262, 143, MACRO DOMAINS ARE ADP-RIBOSE BINDING MOLECULES
105, p4iqyB_, 0.6975, 2.99, 0.084, 262, 143, CRYSTAL STRUCTURE OF THE HUMAN PROTEIN-PROXIMAL ADP-RIBOSYL-HYDROLASE MACROD2
106, p4umlA_, 0.6969, 2.74, 0.121, 185, 140, CRYSTAL STRUCTURE OF GANGLIOSIDE INDUCED DIFFERENTIATION ASSOCIATED PROTEIN 2 (GDAP2) MACRO DOMAIN
107, d1vhuA_, 0.6961, 2.74, 0.121, 185, 140, CRYSTAL STRUCTURE OF A PUTATIVE PHOSPHOESTERASE
108, p4gvwA_, 0.6960, 2.77, 0.100, 170, 140, THREE-DIMENSIONAL STRUCTURE OF THE DE NOVO DESIGNED SERINE HYDROLASE 2BFQ_3 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR248
109, p4iqyA_, 0.6955, 2.78, 0.121, 185, 140, CRYSTAL STRUCTURE OF THE HUMAN PROTEIN-PROXIMAL ADP-RIBOSYL-HYDROLASE MACROD2
110, d2fxkA1, 0.6955, 2.78, 0.121, 185, 140, CRYSTAL STRUCTURE OF THE MACRO-DOMAIN OF HUMAN CORE HISTONE VARIANT MACROH2A1.1 (FORM A)
111, d3iifA_, 0.6950, 2.74, 0.092, 188, 141, CRYSTAL STRUCTURE OF THE MACRO DOMAIN OF HUMAN HISTONE MACROH2A1.1 IN COMPLEX WITH ADP-RIBOSE (FORM B)
112, d1zr3D_, 0.6949, 2.76, 0.092, 188, 141, CRYSTAL STRUCTURE OF THE MACRO-DOMAIN OF HUMAN CORE HISTONE VARIANT MACROH2A1.1 (FORM B)
113, d1zq0B_, 0.6948, 2.78, 0.113, 186, 141,  
114, d1zq0A_, 0.6946, 3.05, 0.125, 191, 144,  
115, p3kr5C2, 0.6945, 2.95, 0.113, 219, 142, STRUCTURE OF A PROTEASE 4
116, d1zq0D_, 0.6944, 2.85, 0.120, 201, 142,  
117, d1zq0C_, 0.6941, 2.85, 0.120, 201, 142,  
118, d1zr3B_, 0.6940, 2.81, 0.144, 187, 139, CRYSTAL STRUCTURE OF THE MACRO-DOMAIN OF HUMAN CORE HISTONE VARIANT MACROH2A1.1 (FORM B)
119, d3iifB_, 0.6936, 3.10, 0.118, 192, 144, CRYSTAL STRUCTURE OF THE MACRO DOMAIN OF HUMAN HISTONE MACROH2A1.1 IN COMPLEX WITH ADP-RIBOSE (FORM B)
120, p5iitA3, 0.6932, 2.98, 0.113, 221, 142, STRUCTURE OF SPX DOMAIN OF THE YEAST INORGANIC POLYPHOPHATE POLYMERASE VTC4 CRYSTALLIZED BY CARRIER-DRIVEN CRYSTALLIZATION IN FUSION WITH THE MACRO DOMAIN OF HUMAN HISTONE MACROH2A1.1
121, d2fxkB_, 0.6932, 2.78, 0.092, 187, 141, CRYSTAL STRUCTURE OF THE MACRO-DOMAIN OF HUMAN CORE HISTONE VARIANT MACROH2A1.1 (FORM A)
122, d1yd9B_, 0.6926, 2.82, 0.116, 183, 138, 1.6A CRYSTAL STRUCTURE OF THE NON-HISTONE DOMAIN OF THE HISTONE VARIANT MACROH2A1.1.
123, d5o2dA_, 0.6925, 2.79, 0.099, 184, 141, PARP14 MACRODOMAIN 2 WITH INHIBITOR
124, d1yd9D_, 0.6922, 2.78, 0.092, 188, 141, 1.6A CRYSTAL STRUCTURE OF THE NON-HISTONE DOMAIN OF THE HISTONE VARIANT MACROH2A1.1.
125, p5iitC3, 0.6917, 2.78, 0.092, 188, 141, STRUCTURE OF SPX DOMAIN OF THE YEAST INORGANIC POLYPHOPHATE POLYMERASE VTC4 CRYSTALLIZED BY CARRIER-DRIVEN CRYSTALLIZATION IN FUSION WITH THE MACRO DOMAIN OF HUMAN HISTONE MACROH2A1.1
126, d3iifC_, 0.6909, 3.07, 0.140, 185, 143, CRYSTAL STRUCTURE OF THE MACRO DOMAIN OF HUMAN HISTONE MACROH2A1.1 IN COMPLEX WITH ADP-RIBOSE (FORM B)
127, p5fszA_, 0.6908, 2.78, 0.092, 188, 141, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI MACRODOMAIN
128, p3kr5G2, 0.6908, 2.79, 0.092, 188, 141, STRUCTURE OF A PROTEASE 4
129, p3kqzC2, 0.6904, 2.80, 0.099, 186, 141, STRUCTURE OF A PROTEASE 2
130, p3kr5I2, 0.6897, 2.85, 0.116, 182, 138, STRUCTURE OF A PROTEASE 4
131, p5lncB2, 0.6890, 2.77, 0.100, 183, 140, STRUCTURE OF SPX DOMAIN OF THE YEAST INORGANIC POLYPHOPHATE POLYMERASE VTC4 CRYSTALLIZED BY CARRIER-DRIVEN CRYSTALLIZATION IN FUSION WITH THE MACRO DOMAIN OF HUMAN HISTONE MACROH2A1.1
132, d2xd7D_, 0.6890, 2.79, 0.099, 187, 141, CRYSTAL STRUCTURE OF THE MACRO DOMAIN OF HUMAN CORE HISTONE H2A
133, p3sijA_, 0.6887, 2.81, 0.099, 187, 141, THE X-RAY CRYSTAL STRUCTURE OF POLY(ADP-RIBOSE) GLYCOHYDROLASE E115A MUTANT FROM THERMOMONOSPORA CURVATA
134, d2xd7B_, 0.6887, 3.16, 0.090, 189, 144, CRYSTAL STRUCTURE OF THE MACRO DOMAIN OF HUMAN CORE HISTONE H2A
135, p3kr5A2, 0.6886, 2.81, 0.099, 188, 141, STRUCTURE OF A PROTEASE 4
136, p3sihA_, 0.6884, 2.82, 0.099, 186, 141, THE X-RAY CRYSTAL STRUCTURE OF POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) FROM THERMOMONOSPORA CURVATA
137, d2xd7C_, 0.6883, 2.94, 0.115, 182, 139, CRYSTAL STRUCTURE OF THE MACRO DOMAIN OF HUMAN CORE HISTONE H2A
138, d2xd7A_, 0.6883, 2.65, 0.096, 229, 136, CRYSTAL STRUCTURE OF THE MACRO DOMAIN OF HUMAN CORE HISTONE H2A
139, d3iidA_, 0.6876, 3.06, 0.140, 183, 143, CRYSTAL STRUCTURE OF THE MACRO DOMAIN OF HUMAN HISTONE MACROH2A1.1 IN COMPLEX WITH ADP-RIBOSE (FORM A)
140, p3kr4C2, 0.6874, 3.12, 0.147, 185, 143, STRUCTURE OF A PROTEASE 3
141, p6fy5A_, 0.6872, 3.10, 0.140, 191, 143, CRYSTAL STRUCTURE OF THE MACRO DOMAIN OF HUMAN MACROH2A2
142, p4r7mC2, 0.6871, 3.10, 0.140, 191, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
143, p3kr5B2, 0.6871, 2.85, 0.099, 188, 141, STRUCTURE OF A PROTEASE 4
144, p3kr4I2, 0.6871, 3.00, 0.106, 187, 142, STRUCTURE OF A PROTEASE 3
145, p4zy0I2, 0.6869, 3.11, 0.104, 265, 144, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
146, p6fy5B_, 0.6866, 3.00, 0.106, 192, 142, CRYSTAL STRUCTURE OF THE MACRO DOMAIN OF HUMAN MACROH2A2
147, p4zx9I2, 0.6866, 3.08, 0.133, 184, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
148, p4k3nC2, 0.6865, 3.13, 0.111, 274, 144, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
149, p5cbmC2, 0.6864, 3.13, 0.111, 274, 144, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
150, p4zy2I2, 0.6864, 3.00, 0.106, 193, 142, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
151, p4zx9C2, 0.6864, 3.00, 0.106, 193, 142, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
152, p4zx8I2, 0.6863, 3.00, 0.106, 192, 142, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
153, p4k3nI2, 0.6863, 3.07, 0.107, 185, 140, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
154, p5cbmI2, 0.6861, 3.14, 0.147, 185, 143, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
155, p4zy2C2, 0.6861, 2.87, 0.113, 198, 141, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
156, p4zy1C2, 0.6859, 3.11, 0.133, 185, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
157, p4r7mI2, 0.6859, 3.09, 0.140, 185, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
158, p3siiA_, 0.6859, 3.14, 0.147, 185, 143, THE X-RAY CRYSTAL STRUCTURE OF POLY(ADP-RIBOSE) GLYCOHYDROLASE BOUND TO THE INHIBITOR ADP-HPD FROM THERMOMONOSPORA CURVATA
159, p3kr4B2, 0.6859, 3.13, 0.147, 185, 143, STRUCTURE OF A PROTEASE 3
160, p3t8wC2, 0.6855, 2.84, 0.106, 193, 141, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
161, p4r6tC2, 0.6854, 3.14, 0.147, 183, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
162, p4zy1A2, 0.6853, 3.13, 0.147, 185, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
163, p4zx8C2, 0.6853, 3.13, 0.147, 185, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
164, p4k3nG2, 0.6853, 3.14, 0.147, 183, 143, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
165, p3kqxC2, 0.6851, 3.14, 0.147, 185, 143, STRUCTURE OF A PROTEASE 1
166, p4zy1I2, 0.6850, 3.14, 0.147, 183, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
167, p5cbmB2, 0.6849, 3.13, 0.147, 185, 143, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
168, p3t8wI2, 0.6849, 3.13, 0.140, 183, 143, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
169, p4zx9A2, 0.6848, 3.14, 0.147, 185, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
170, p3t8wH2, 0.6847, 3.14, 0.140, 185, 143, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
171, p4zyqI2, 0.6846, 3.13, 0.147, 181, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
172, p4zx9G2, 0.6846, 3.10, 0.098, 265, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
173, p4r76I2, 0.6846, 3.24, 0.146, 185, 144, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
174, p4r76C2, 0.6846, 3.14, 0.147, 185, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
175, p4x2tC2, 0.6844, 3.13, 0.147, 185, 143, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
176, p4zyqC2, 0.6843, 3.14, 0.147, 183, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
177, p4zy2H2, 0.6843, 3.14, 0.147, 183, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
178, p4zy0C2, 0.6842, 3.14, 0.147, 185, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
179, p4k3nB2, 0.6842, 3.27, 0.146, 183, 144, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
180, p4zy0G2, 0.6841, 3.14, 0.140, 185, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
181, p3t8wA2, 0.6841, 3.26, 0.146, 184, 144, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
182, p4zyqG2, 0.6840, 3.15, 0.147, 185, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
183, p5cbmH2, 0.6836, 3.14, 0.147, 185, 143, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
184, p5cbmA2, 0.6836, 3.25, 0.146, 185, 144, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
185, p4zy0A2, 0.6836, 3.15, 0.147, 183, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
186, p4k3nH2, 0.6836, 3.15, 0.147, 185, 143, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
187, p4zx8A2, 0.6835, 3.14, 0.147, 181, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
188, p4k3nA2, 0.6835, 3.14, 0.140, 183, 143, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
189, p3t8wB2, 0.6835, 3.16, 0.140, 183, 143, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
190, p4zy2B2, 0.6834, 3.15, 0.140, 183, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
191, p4zx9H2, 0.6834, 3.16, 0.147, 185, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
192, p4x2tG2, 0.6833, 3.16, 0.147, 185, 143, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
193, p4zy1B2, 0.6829, 3.12, 0.133, 185, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
194, p3kqzI2, 0.6828, 3.15, 0.147, 183, 143, STRUCTURE OF A PROTEASE 2
195, p5cbmG2, 0.6827, 3.15, 0.147, 185, 143, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
196, p4zy2A2, 0.6827, 3.16, 0.147, 183, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
197, p4zx9B2, 0.6827, 3.24, 0.139, 184, 144, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
198, p5fsvA_, 0.6826, 3.16, 0.147, 185, 143, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI MACRODOMAIN (CRYSTAL FORM 2)
199, p4zy2G2, 0.6825, 3.16, 0.147, 183, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
200, p4zy1G2, 0.6823, 3.15, 0.147, 183, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
201, p4zy1H2, 0.6822, 3.15, 0.140, 183, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
202, p4r7mA2, 0.6822, 3.16, 0.147, 185, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
203, p4r76G2, 0.6822, 3.16, 0.147, 184, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
204, p4zx8G2, 0.6820, 3.16, 0.147, 184, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
205, p3t8wG2, 0.6817, 3.15, 0.140, 184, 143, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
206, p3kr4G2, 0.6817, 3.15, 0.140, 185, 143, STRUCTURE OF A PROTEASE 3
207, p3kr4A2, 0.6815, 3.15, 0.140, 182, 143, STRUCTURE OF A PROTEASE 3
208, p4r6tI2, 0.6813, 3.16, 0.133, 182, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
209, p4ksiA2, 0.6813, 3.16, 0.140, 183, 143, CRYSTAL STRUCTURE ANALYSIS OF THE ACIDIC LEUCINE AMINOPEPTIDASE OF TOMATO
210, p4zy0H2, 0.6812, 3.17, 0.147, 185, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
211, p3sigA_, 0.6811, 3.17, 0.147, 184, 143, THE X-RAY CRYSTAL STRUCTURE OF POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) BOUND TO ADP-RIBOSE FROM THERMOMONOSPORA CURVATA
212, p4r7mB2, 0.6810, 2.74, 0.096, 232, 136, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
213, p4zx8B2, 0.6808, 3.15, 0.140, 184, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
214, p4zyqB2, 0.6807, 3.15, 0.140, 183, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
215, p4zx8H2, 0.6807, 3.15, 0.140, 182, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
216, p5d8nC2, 0.6806, 3.16, 0.140, 183, 143, TOMATO LEUCINE AMINOPEPTIDASE MUTANT - K354E
217, p4r76H2, 0.6806, 3.14, 0.133, 184, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
218, p4zy0B2, 0.6805, 3.17, 0.147, 185, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
219, p4zyqH2, 0.6803, 3.15, 0.133, 184, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
220, p5d8nA2, 0.6802, 3.16, 0.140, 183, 143, TOMATO LEUCINE AMINOPEPTIDASE MUTANT - K354E
221, p4x2tA2, 0.6797, 3.15, 0.133, 184, 143, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
222, p4jgkD_, 0.6796, 3.16, 0.140, 181, 143, CRYSTAL STRUCTURE OF THE EVOLVED VARIANT OF THE COMPUTATIONALLY DESIGNED SERINE HYDROLASE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR275
223, p4jgkC_, 0.6793, 3.16, 0.154, 184, 143, CRYSTAL STRUCTURE OF THE EVOLVED VARIANT OF THE COMPUTATIONALLY DESIGNED SERINE HYDROLASE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR275
224, p5d8nB2, 0.6792, 3.16, 0.154, 184, 143, TOMATO LEUCINE AMINOPEPTIDASE MUTANT - K354E
225, p4zyqA2, 0.6789, 3.17, 0.140, 189, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
226, p5fsyA_, 0.6777, 3.30, 0.110, 265, 145, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI MACRODOMAIN IN COMPLEX WITH ADP-RIBOSE
227, p2x47A_, 0.6777, 3.11, 0.134, 181, 142, CRYSTAL STRUCTURE OF HUMAN MACROD1
228, p3kqxI2, 0.6773, 3.18, 0.147, 184, 143, STRUCTURE OF A PROTEASE 1
229, p4r76A2, 0.6770, 3.17, 0.147, 184, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
230, p5fsuB_, 0.6768, 3.18, 0.140, 189, 143, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI MACRODOMAIN (CRYSTAL FORM 1)
231, p4x2tI2, 0.6766, 3.17, 0.161, 183, 143, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
232, p5fsxA_, 0.6760, 3.16, 0.133, 180, 143, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI MACRODOMAIN IN COMPLEX WITH ADP
233, p4r6tE2, 0.6760, 3.18, 0.140, 183, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
234, p4jgkB_, 0.6743, 3.17, 0.140, 184, 143, CRYSTAL STRUCTURE OF THE EVOLVED VARIANT OF THE COMPUTATIONALLY DESIGNED SERINE HYDROLASE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR275
235, p5fsxB_, 0.6741, 3.16, 0.154, 183, 143, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI MACRODOMAIN IN COMPLEX WITH ADP
236, p4r7mD2, 0.6740, 3.18, 0.140, 181, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
237, p5fsuA_, 0.6739, 2.95, 0.109, 166, 137, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI MACRODOMAIN (CRYSTAL FORM 1)
238, p3kqzG2, 0.6715, 2.93, 0.109, 165, 137, STRUCTURE OF A PROTEASE 2
239, p4r7mG2, 0.6714, 3.18, 0.154, 183, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
240, p3kqzA2, 0.6708, 3.20, 0.126, 181, 143, STRUCTURE OF A PROTEASE 2
241, d2dx6A_, 0.6707, 2.87, 0.095, 232, 137, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN TTHA0132 FROM THERMUS THERMOPHILUS HB8
242, p3kr5L2, 0.6704, 3.20, 0.113, 229, 142, STRUCTURE OF A PROTEASE 4
243, p5lhjA1, 0.6703, 3.20, 0.113, 229, 142, BOTTROMYCIN MATURATION ENZYME BOTP
244, p5ailB_, 0.6702, 3.16, 0.141, 182, 142, HUMAN PARP9 2ND MACRODOMAIN
245, d2dx6B_, 0.6700, 3.16, 0.148, 182, 142, CRYSTAL STRUCTURE OF CONSERVED HYPOTHETICAL PROTEIN TTHA0132 FROM THERMUS THERMOPHILUS HB8
246, p5ailA_, 0.6698, 2.82, 0.096, 240, 136, HUMAN PARP9 2ND MACRODOMAIN
247, p3kr5J2, 0.6694, 2.82, 0.096, 240, 136, STRUCTURE OF A PROTEASE 4
248, p4zy2E2, 0.6693, 3.22, 0.133, 180, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
249, p4jgkA_, 0.6692, 2.80, 0.096, 233, 136, CRYSTAL STRUCTURE OF THE EVOLVED VARIANT OF THE COMPUTATIONALLY DESIGNED SERINE HYDROLASE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR275
250, p4r6tB2, 0.6691, 3.23, 0.126, 181, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
251, p4etjA_, 0.6690, 2.96, 0.096, 165, 136, CRYSTAL STRUCTURE OF E6H VARIANT OF DE NOVO DESIGNED SERINE HYDROLASE OSH55 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR185
252, p3kr5D2, 0.6690, 2.90, 0.095, 232, 137, STRUCTURE OF A PROTEASE 4
253, p4zy2L2, 0.6686, 3.37, 0.146, 181, 144, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
254, p3kr5F2, 0.6686, 2.98, 0.080, 235, 138, STRUCTURE OF A PROTEASE 4
255, p4r6tG2, 0.6685, 3.17, 0.135, 180, 141, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
256, p4essA_, 0.6682, 3.27, 0.141, 180, 142, CRYSTAL STRUCTURE OF E6D/L155R VARIANT OF DE NOVO DESIGNED SERINE HYDROLASE OSH55 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR187
257, p4r7mL2, 0.6680, 3.18, 0.135, 180, 141, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
258, p4r6tA2, 0.6680, 2.92, 0.141, 157, 135, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
259, p4r76D2, 0.6676, 3.14, 0.143, 178, 140, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
260, p4zyqD2, 0.6672, 2.27, 0.242, 138, 124, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
261, p3kzwH1, 0.6670, 2.27, 0.242, 138, 124, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
262, p3kzwK1, 0.6669, 3.03, 0.088, 182, 137, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
263, p3kzwF1, 0.6669, 3.03, 0.088, 182, 137, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
264, p3kqzE2, 0.6668, 2.98, 0.141, 157, 135, STRUCTURE OF A PROTEASE 2
265, p4r76B2, 0.6667, 3.03, 0.088, 180, 137, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
266, p3kzwE1, 0.6667, 3.28, 0.141, 180, 142, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
267, p3kzwC1, 0.6667, 3.25, 0.141, 179, 142, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
268, p3kzwB1, 0.6667, 3.06, 0.109, 164, 137, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
269, p4zy2K2, 0.6666, 3.24, 0.141, 178, 142, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
270, p4zx9F2, 0.6666, 3.14, 0.117, 164, 137, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
271, p4r7mJ2, 0.6666, 3.08, 0.136, 179, 140, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
272, p3kzwD1, 0.6666, 3.27, 0.141, 180, 142, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
273, p3kr5E2, 0.6666, 3.18, 0.136, 177, 140, STRUCTURE OF A PROTEASE 4
274, p3kzwI1, 0.6665, 3.30, 0.148, 180, 142, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
275, p3kzwG1, 0.6665, 2.98, 0.104, 158, 135, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
276, p3kzwA1, 0.6665, 3.29, 0.135, 176, 141, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
277, p3kzwL1, 0.6664, 3.31, 0.148, 180, 142, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
278, p4x2tH2, 0.6663, 3.33, 0.140, 181, 143, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
279, p4zy2F2, 0.6662, 3.27, 0.148, 178, 142, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
280, p4x2tF2, 0.6662, 3.32, 0.168, 177, 143, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
281, p4r7mE2, 0.6662, 3.32, 0.168, 177, 143, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
282, p4k3nF2, 0.6662, 3.32, 0.168, 177, 143, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
283, p3v45A_, 0.6662, 3.18, 0.136, 175, 140, CRYSTAL STRUCTURE OF DE NOVO DESIGNED SERINE HYDROLASE OSH55 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OR130
284, p4r6tL2, 0.6661, 3.22, 0.142, 179, 141, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
285, p4k3nL2, 0.6661, 3.33, 0.168, 177, 143, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
286, p3kzwJ1, 0.6660, 3.33, 0.168, 177, 143, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM STAPHYLOCOCCUS AUREUS COL
287, p4zx9D2, 0.6658, 3.33, 0.168, 177, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
288, p3kqzF2, 0.6658, 3.24, 0.142, 180, 141, STRUCTURE OF A PROTEASE 2
289, p3kqzK2, 0.6657, 3.26, 0.142, 176, 141, STRUCTURE OF A PROTEASE 2
290, p4zy1D2, 0.6656, 3.19, 0.143, 178, 140, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
291, p4zx8F2, 0.6655, 3.33, 0.168, 177, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
292, p4x2tB2, 0.6655, 3.16, 0.143, 178, 140, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
293, p3kqzD2, 0.6654, 3.33, 0.168, 177, 143, STRUCTURE OF A PROTEASE 2
294, p4zy0F2, 0.6652, 3.33, 0.168, 177, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
295, p3t8wL2, 0.6652, 3.33, 0.168, 177, 143, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
296, p3kr4D2, 0.6651, 3.33, 0.168, 177, 143, STRUCTURE OF A PROTEASE 3
297, p4zx8L2, 0.6650, 3.34, 0.168, 176, 143, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
298, d1zr5A1, 0.6649, 3.24, 0.142, 177, 141, CRYSTAL STRUCTURE OF THE MACRO-DOMAIN OF HUMAN CORE HISTONE VARIANT MACROH2A1.2
299, p4k3nE2, 0.6648, 3.31, 0.134, 179, 142, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
300, p4k3nD2, 0.6648, 3.18, 0.143, 175, 140, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
301, p3kqzL2, 0.6648, 3.26, 0.135, 176, 141, STRUCTURE OF A PROTEASE 2
302, p4zyqF2, 0.6647, 3.29, 0.149, 176, 141, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
303, p4r7mK2, 0.6647, 3.04, 0.103, 166, 136, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
304, p3kqzH2, 0.6647, 3.04, 0.103, 166, 136, STRUCTURE OF A PROTEASE 2
305, p4zx9L2, 0.6646, 3.30, 0.135, 176, 141, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
306, p3t8wF2, 0.6646, 3.17, 0.143, 178, 140, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
307, p5lhkA1, 0.6645, 3.32, 0.168, 177, 143, BOTTROMYCIN MATURATION ENZYME BOTP IN COMPLEX WITH MN
308, p4zx9E2, 0.6645, 3.30, 0.141, 180, 142, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
309, d1zr5B_, 0.6645, 3.19, 0.143, 177, 140, CRYSTAL STRUCTURE OF THE MACRO-DOMAIN OF HUMAN CORE HISTONE VARIANT MACROH2A1.2
310, p4r76L2, 0.6643, 3.19, 0.136, 177, 140, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
311, p4zx8E2, 0.6642, 3.30, 0.141, 178, 142, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
312, p4r76F2, 0.6642, 3.24, 0.142, 178, 141, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
313, p4zyqL2, 0.6641, 3.27, 0.149, 179, 141, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
314, p4zy0D2, 0.6641, 3.34, 0.141, 180, 142, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
315, p4zx8J2, 0.6641, 3.20, 0.143, 177, 140, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
316, p3kqzJ2, 0.6641, 3.17, 0.143, 178, 140, STRUCTURE OF A PROTEASE 2
317, p3kqxG2, 0.6640, 3.38, 0.133, 182, 143, STRUCTURE OF A PROTEASE 1
318, p4r7mF2, 0.6638, 3.26, 0.142, 177, 141, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
319, p3kqzB2, 0.6637, 3.08, 0.092, 189, 141, STRUCTURE OF A PROTEASE 2
320, p3kqxA2, 0.6636, 3.18, 0.143, 178, 140, STRUCTURE OF A PROTEASE 1
321, p4zy2J2, 0.6635, 3.32, 0.141, 180, 142, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
322, p4zy1L2, 0.6635, 3.17, 0.122, 175, 139, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
323, p4zy2D2, 0.6634, 3.19, 0.143, 176, 140, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10O
324, p4zy0L2, 0.6634, 3.21, 0.136, 177, 140, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
325, p4r6tJ2, 0.6634, 3.14, 0.151, 177, 139, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
326, p4k0cB_, 0.6634, 3.19, 0.143, 178, 140, CRYSTAL STRUCTURE OF THE COMPUTATIONALLY DESIGNED SERINE HYDROLASE. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR317
327, p4r7mH2, 0.6632, 3.19, 0.143, 178, 140, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
328, p4r6tD2, 0.6631, 2.21, 0.246, 136, 122, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
329, p4zx8D2, 0.6630, 3.20, 0.136, 175, 140, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
330, p4x2tE2, 0.6630, 3.08, 0.092, 187, 141, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
331, p4k3nK2, 0.6629, 3.28, 0.135, 175, 141, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
332, p4zy1E2, 0.6628, 3.28, 0.135, 176, 141, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
333, p4zx8K2, 0.6628, 3.29, 0.142, 177, 141, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 9B
334, p3kr4E2, 0.6628, 3.19, 0.143, 176, 140, STRUCTURE OF A PROTEASE 3
335, p4zyqJ2, 0.6627, 3.32, 0.141, 180, 142, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
336, p3t8wJ2, 0.6627, 3.25, 0.142, 179, 141, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
337, p3t8wD2, 0.6627, 3.24, 0.128, 180, 141, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
338, p4zyqE2, 0.6626, 3.25, 0.135, 180, 141, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
339, p4zy1K2, 0.6626, 3.21, 0.136, 175, 140, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
340, p4zx9K2, 0.6626, 3.15, 0.144, 177, 139, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
341, p3kr5H2, 0.6626, 3.25, 0.135, 180, 141, STRUCTURE OF A PROTEASE 4
342, p3kqxF2, 0.6626, 3.33, 0.141, 180, 142, STRUCTURE OF A PROTEASE 1
343, p4zyqK2, 0.6625, 3.21, 0.143, 175, 140, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10S
344, p4zy1J2, 0.6624, 3.33, 0.141, 180, 142, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
345, p5cbmF2, 0.6623, 3.20, 0.143, 178, 140, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
346, p4x2tK2, 0.6623, 3.31, 0.149, 176, 141, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
347, p4zy1F2, 0.6621, 3.11, 0.125, 160, 136, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10R
348, p4r6tK2, 0.6621, 3.21, 0.143, 178, 140, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
349, p4zy0J2, 0.6620, 3.27, 0.142, 177, 141, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
350, p4r76E2, 0.6620, 3.25, 0.142, 179, 141, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
351, p3kr4L2, 0.6620, 3.22, 0.136, 175, 140, STRUCTURE OF A PROTEASE 3
352, p5cbmD2, 0.6619, 3.21, 0.136, 177, 140, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
353, p4r76K2, 0.6616, 3.22, 0.136, 175, 140, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
354, p4zx9J2, 0.6615, 3.23, 0.136, 183, 140, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10B
355, p4zy0E2, 0.6614, 3.20, 0.143, 178, 140, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
356, p4k3nJ2, 0.6614, 3.24, 0.142, 179, 141, PHOSPHONIC ARGININE MIMETICS AS INHIBITORS OF THE M17 AMINOPEPTIDASES FROM PLASMODIUM FALCIPARUM
357, p3kqxL2, 0.6614, 3.32, 0.141, 180, 142, STRUCTURE OF A PROTEASE 1
358, p3kr5K2, 0.6613, 3.33, 0.141, 180, 142, STRUCTURE OF A PROTEASE 4
359, p5cbmL2, 0.6612, 3.23, 0.136, 175, 140, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
360, p5cbmK2, 0.6611, 3.23, 0.136, 175, 140, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
361, p3kqxE2, 0.6611, 3.23, 0.136, 177, 140, STRUCTURE OF A PROTEASE 1
362, p3kr4J2, 0.6609, 3.18, 0.137, 174, 139, STRUCTURE OF A PROTEASE 3
363, p3kr4H2, 0.6607, 3.21, 0.143, 175, 140, STRUCTURE OF A PROTEASE 3
364, p3t8wK2, 0.6605, 3.21, 0.136, 177, 140, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
365, p4r6tF2, 0.6604, 3.32, 0.141, 180, 142, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
366, p4x2tD2, 0.6603, 3.22, 0.143, 176, 140, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
367, p4r76J2, 0.6603, 3.23, 0.136, 177, 140, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
368, p3t8wE2, 0.6603, 3.21, 0.143, 176, 140, A BESTATIN-BASED CHEMICAL BIOLOGY STRATEGY REVEALS DISTINCT ROLES FOR MALARIA M1- AND M17-FAMILY AMINOPEPTIDASES
369, p4zy0K2, 0.6602, 3.22, 0.136, 175, 140, X-RAY CRYSTAL STRUCTURE OF PFA-M17 IN COMPLEX WITH HYDROXAMIC ACID- BASED INHIBITOR 10Q
370, p5cbmE2, 0.6601, 3.32, 0.141, 180, 142, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
371, p4r6tH2, 0.6599, 3.29, 0.135, 178, 141, STRUCTURE OF THE M17 LEUCYL AMINOPEPTIDASE FROM MALARIA COMPLEXED WITH A HYDROXAMIC ACID-BASED INHIBITOR
372, p5cbmJ2, 0.6596, 3.21, 0.143, 178, 140, CRYSTAL STRUCTURE OF PFA-M17 WITH VIRTUAL LIGAND INHIBITOR
373, p3kqxK2, 0.6595, 3.36, 0.134, 180, 142, STRUCTURE OF A PROTEASE 1
374, p4x2tJ2, 0.6594, 3.24, 0.136, 175, 140, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
375, p3kr4F2, 0.6594, 3.26, 0.142, 177, 141, STRUCTURE OF A PROTEASE 3
376, p3kqxJ2, 0.6586, 3.22, 0.136, 175, 140, STRUCTURE OF A PROTEASE 1
377, p3kqxD2, 0.6585, 3.27, 0.142, 179, 141, STRUCTURE OF A PROTEASE 1
378, p3kqxH2, 0.6580, 3.30, 0.136, 173, 140, STRUCTURE OF A PROTEASE 1
379, p3kr4K2, 0.6577, 3.28, 0.143, 176, 140, STRUCTURE OF A PROTEASE 3
380, p4x2tL2, 0.6576, 3.23, 0.143, 178, 140, X-RAY CRYSTAL STRUCTURE OF THE ORALLY AVAILABLE AMINOPEPTIDASE INHIBITOR TOSEDOSTAT BOUND TO THE M17 LEUCYL AMINOPEPTIDASE FROM P. FALCIPARUM
381, p3kqxB2, 0.6575, 3.23, 0.136, 175, 140, STRUCTURE OF A PROTEASE 1
382, p4gvvD_, 0.6565, 3.24, 0.136, 175, 140, CRYSTAL STRUCTURE OF DE NOVO DESIGN SERINE HYDROLASE OSH55.27 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR246
383, p4gvvB_, 0.6564, 3.39, 0.134, 180, 142, CRYSTAL STRUCTURE OF DE NOVO DESIGN SERINE HYDROLASE OSH55.27 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR246
384, p4kybA_, 0.6544, 3.19, 0.137, 176, 139, CRYSTAL STRUCTURE OF DE NOVO DESIGNED SERINE HYDROLASE OSH55.14_E3 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OR342
385, p4jcaA_, 0.6543, 3.24, 0.136, 177, 140, CRYSTAL STRUCTURE OF THE APO FORM OF THE EVOLVED VARIANT OF THE COMPUTATIONALLY DESIGNED SERINE HYDROLASE OSH55.4_H1. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR273
386, p4k0cA_, 0.6535, 3.29, 0.143, 176, 140, CRYSTAL STRUCTURE OF THE COMPUTATIONALLY DESIGNED SERINE HYDROLASE. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR317
387, p4gvvC_, 0.6533, 3.23, 0.143, 176, 140, CRYSTAL STRUCTURE OF DE NOVO DESIGN SERINE HYDROLASE OSH55.27 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR246
388, p4gvvA_, 0.6528, 3.22, 0.143, 176, 140, CRYSTAL STRUCTURE OF DE NOVO DESIGN SERINE HYDROLASE OSH55.27 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR246
389, p5ntgA2, 0.6514, 3.24, 0.136, 175, 140, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA CRUZI IN COMPLEX WITH CITRATE
390, p5ntgB2, 0.6509, 3.23, 0.136, 183, 140, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA CRUZI IN COMPLEX WITH CITRATE
391, p5nskC1, 0.6502, 3.24, 0.136, 177, 140, APO STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
392, p4efdE1, 0.6502, 3.26, 0.143, 176, 140, CRYSTAL STRUCTURE OF AN M17 AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI TB427TMP.02.4440
393, p5nskF2, 0.6495, 3.38, 0.141, 178, 142, APO STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
394, p4etkA_, 0.6491, 3.25, 0.136, 177, 140, CRYSTAL STRUCTURE OF E6A/L130D/A155H VARIANT OF DE NOVO DESIGNED SERINE HYDROLASE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR186
395, p5ntfA2, 0.6477, 3.14, 0.129, 176, 139, APO STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
396, p5ntdA2, 0.6476, 3.26, 0.136, 177, 140, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
397, p4etkB_, 0.6476, 3.40, 0.141, 178, 142, CRYSTAL STRUCTURE OF E6A/L130D/A155H VARIANT OF DE NOVO DESIGNED SERINE HYDROLASE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR186
398, p4jvvA_, 0.6473, 3.40, 0.141, 178, 142, CRYSTAL STRUCTURE OF THE EVOLVED VARIANT OF THE COMPUTATIONALLY DESIGNED SERINE HYDROLASE OSH55.4_H1 COVALENTLY BOUND WITH DIISOPROPYL FLUOROPHOSPHATE (DFP) NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR273
399, p5ntdJ2, 0.6471, 3.32, 0.150, 177, 140, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
400, p5ntdG2, 0.6470, 3.23, 0.137, 176, 139, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
401, p5ntdF2, 0.6470, 3.24, 0.137, 175, 139, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
402, p3v2bA_, 0.6470, 3.32, 0.150, 177, 140, HUMAN POLY(ADP-RIBOSE) POLYMERASE 15 (ARTD7 BAL3) MACRO DOMAIN 2 IN COMPLEX WITH ADENOSINE-5-DIPHOSPHORIBOSE
403, p5ntdK1, 0.6468, 3.15, 0.118, 157, 136, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
404, p5ntdE2, 0.6468, 3.12, 0.103, 159, 136, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
405, p5nskE1, 0.6468, 3.26, 0.102, 163, 137, APO STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
406, p5ntdB2, 0.6467, 3.34, 0.109, 160, 137, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
407, p5nskA2, 0.6466, 3.14, 0.118, 159, 136, APO STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
408, p4zlaD1, 0.6465, 3.28, 0.110, 165, 136, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
409, p5nskB1, 0.6464, 3.23, 0.110, 164, 136, APO STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
410, p4zlaC1, 0.6464, 3.33, 0.114, 180, 140, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
411, p5nsmE2, 0.6461, 3.34, 0.114, 180, 140, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
412, p5nsmH2, 0.6459, 3.31, 0.114, 201, 140, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
413, p4zi6E1, 0.6457, 3.37, 0.121, 201, 141, CRYSTAL STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
414, p4efdC1, 0.6456, 3.31, 0.114, 191, 140, CRYSTAL STRUCTURE OF AN M17 AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI TB427TMP.02.4440
415, p5nsmJ2, 0.6454, 3.29, 0.103, 165, 136, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
416, p5nsmC2, 0.6454, 3.40, 0.106, 180, 141, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
417, p4zi6D1, 0.6453, 3.39, 0.135, 191, 141, CRYSTAL STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
418, p5nsmG2, 0.6452, 3.31, 0.110, 164, 136, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
419, p5nsmL2, 0.6451, 3.39, 0.119, 156, 135, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
420, p4zlaA1, 0.6451, 3.41, 0.128, 191, 141, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
421, p4zlaE1, 0.6449, 3.31, 0.136, 191, 140, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
422, p4zi6C1, 0.6448, 3.42, 0.128, 191, 141, CRYSTAL STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
423, p4zi6A1, 0.6447, 3.04, 0.075, 176, 133, CRYSTAL STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
424, p5ntdD2, 0.6446, 3.42, 0.128, 233, 141, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
425, p4kybB_, 0.6446, 3.42, 0.128, 233, 141, CRYSTAL STRUCTURE OF DE NOVO DESIGNED SERINE HYDROLASE OSH55.14_E3 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET OR342
426, p4zi6F1, 0.6445, 3.42, 0.128, 191, 141, CRYSTAL STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
427, p4zlaF1, 0.6444, 3.39, 0.135, 201, 141, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
428, p4efdF1, 0.6444, 3.39, 0.135, 191, 141, CRYSTAL STRUCTURE OF AN M17 AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI TB427TMP.02.4440
429, p4zlaB1, 0.6442, 3.40, 0.135, 191, 141, BESTATIN COMPLEX STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
430, p5ntdL2, 0.6440, 2.76, 0.184, 152, 125, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
431, p5ntdH2, 0.6440, 3.40, 0.135, 201, 141, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
432, p4jllA_, 0.6440, 2.58, 0.200, 156, 125, CRYSTAL STRUCTURE OF THE EVOLVED VARIANT OF THE COMPUTATIONALLY DESIGNED SERINE HYDROLASE OSH55.4_H1 COVALENTLY BOUND WITH FP- ALKYNE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR273
433, p5nsmA2, 0.6438, 3.41, 0.113, 191, 141, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
434, p4abkA_, 0.6438, 3.41, 0.113, 191, 141, HUMAN PARP14 (ARTD8 BAL2) - MACRO DOMAIN 3 IN COMPLEX WITH ADENOSINE-5-DIPHOSPHORIBOSE
435, p5ntdI2, 0.6436, 2.57, 0.200, 155, 125, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
436, p5nskD1, 0.6434, 3.41, 0.113, 200, 141, APO STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
437, p5nsmK2, 0.6433, 3.43, 0.128, 191, 141, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
438, p5ntdC1, 0.6432, 3.41, 0.135, 191, 141, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH BESTATIN
439, p5nsmD2, 0.6431, 2.78, 0.184, 150, 125, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
440, p5nsmI2, 0.6429, 3.41, 0.135, 191, 141, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
441, p5nsmF2, 0.6429, 3.41, 0.135, 191, 141, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
442, p4zi6B1, 0.6428, 2.59, 0.200, 157, 125, CRYSTAL STRUCTURE OF LEUCINE AMINOPEPTIDASE FROM HELICOBACTER PYLORI
443, p5nsmB2, 0.6427, 2.59, 0.200, 157, 125, UNLIGANDED STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
444, p4ablA_, 0.6427, 2.59, 0.200, 156, 125, HUMAN PARP14 (ARTD8 BAL2) - MACRO DOMAIN 3
445, p3gqoA_, 0.6426, 2.59, 0.200, 153, 125, CRYSTAL STRUCTURE OF MACRO DOMAIN OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS IN COMPLEX WITH ADP-RIBOSE
446, d3ewoB_, 0.6425, 2.59, 0.200, 156, 125, IBV NSP3 ADRP DOMAIN
447, p4efdB1, 0.6424, 3.47, 0.128, 191, 141, CRYSTAL STRUCTURE OF AN M17 AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI TB427TMP.02.4440
448, p5ntfB2, 0.6420, 3.32, 0.075, 155, 134, APO STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI
449, p4efdD1, 0.6416, 2.57, 0.200, 152, 125, CRYSTAL STRUCTURE OF AN M17 AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI TB427TMP.02.4440
450, p3gqoC_, 0.6416, 2.58, 0.200, 156, 125, CRYSTAL STRUCTURE OF MACRO DOMAIN OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS IN COMPLEX WITH ADP-RIBOSE
451, p5nsqA2, 0.6411, 3.49, 0.121, 201, 141, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH ACTINONIN
452, p3gqoB_, 0.6411, 2.60, 0.200, 154, 125, CRYSTAL STRUCTURE OF MACRO DOMAIN OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS IN COMPLEX WITH ADP-RIBOSE
453, p3gqoD_, 0.6410, 3.48, 0.128, 191, 141, CRYSTAL STRUCTURE OF MACRO DOMAIN OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS IN COMPLEX WITH ADP-RIBOSE
454, p5nsqD2, 0.6409, 3.48, 0.128, 190, 141, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH ACTINONIN
455, p5nsqB2, 0.6408, 3.46, 0.081, 161, 136, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH ACTINONIN
456, p5nsqC1, 0.6407, 3.49, 0.113, 191, 141, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH ACTINONIN
457, p5nsqE2, 0.6403, 3.16, 0.090, 182, 134, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH ACTINONIN
458, d4na6A_, 0.6397, 3.16, 0.090, 182, 134, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E749N
459, p5mqxA_, 0.6396, 3.48, 0.128, 191, 141, NMR SOLUTION STRUCTURE OF MACRO DOMAIN FROM VENEZUELAN EQUINE ENCEPHALITIS VIRUS(VEEV) IN COMPLEX WITH ADP-RIBOSE 
460, p4efdA1, 0.6392, 3.48, 0.128, 201, 141, CRYSTAL STRUCTURE OF AN M17 AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI TB427TMP.02.4440
461, p4j4zA_, 0.6389, 3.48, 0.128, 191, 141, CRYSTAL STRUCTURE OF THE IMPROVED VARIANT OF THE EVOLVED SERINE HYDROLASE OSH55.4_H1.2 BOND WITH SULFATE ION IN THE ACTIVE SITE NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) TARGET OR301
462, p3peiA1, 0.6386, 3.49, 0.128, 201, 141, CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM FRANCISELLA TULARENSIS
463, p3gpqA_, 0.6381, 3.49, 0.128, 191, 141, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS IN COMPLEX WITH RNA
464, d3ewpB_, 0.6369, 3.49, 0.128, 191, 141, COMPLEX OF SUBSTRATE ADP-RIBOSE WITH IBV NSP3 ADRP DOMAIN
465, d4a0dA_, 0.6363, 3.49, 0.128, 191, 141, STRUCTURE OF UNLIGANDED HUMAN PARG CATALYTIC DOMAIN
466, p4guaB4, 0.6361, 2.62, 0.200, 152, 125, ALPHAVIRUS P23PRO-ZBD
467, p4epqA_, 0.6361, 3.49, 0.128, 191, 141, CANONICAL POLY(ADP-RIBOSE) GLYCOHYDROLASE RBPI INHIBITOR COMPLEX FROM TETRAHYMENA THERMOPHILA
468, d5a7rA_, 0.6360, 3.07, 0.075, 181, 133, HUMAN POLY(ADP-RIBOSE) GLYCOHYDROLASE IN COMPLEX WITH SYNTHETIC DIMERIC ADP-RIBOSE
469, p4guaC4, 0.6360, 2.88, 0.122, 161, 131, ALPHAVIRUS P23PRO-ZBD
470, d3uelA_, 0.6360, 2.77, 0.085, 165, 129, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT POLY (ADP-RIBOSE) GLYCOHYDROLASE BOUND TO ADP-HPD
471, d4b1hA_, 0.6357, 3.50, 0.128, 201, 141, STRUCTURE OF HUMAN PARG CATALYTIC DOMAIN IN COMPLEX WITH ADP-RIBOSE
472, d3uelB_, 0.6357, 3.55, 0.113, 180, 142, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT POLY (ADP-RIBOSE) GLYCOHYDROLASE BOUND TO ADP-HPD
473, d4b1iA_, 0.6355, 3.48, 0.128, 201, 141, STRUCTURE OF HUMAN PARG CATALYTIC DOMAIN IN COMPLEX WITH OA-ADP-HPD
474, d4b1jA_, 0.6354, 2.89, 0.122, 160, 131, STRUCTURE OF HUMAN PARG CATALYTIC DOMAIN IN COMPLEX WITH ADP-HPD
475, p4guaA5, 0.6353, 3.49, 0.121, 191, 141, ALPHAVIRUS P23PRO-ZBD
476, p4eppA_, 0.6352, 2.88, 0.122, 159, 131, CANONICAL POLY(ADP-RIBOSE) GLYCOHYDROLASE FROM TETRAHYMENA THERMOPHILA.
477, d3uelC_, 0.6349, 2.88, 0.122, 160, 131, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT POLY (ADP-RIBOSE) GLYCOHYDROLASE BOUND TO ADP-HPD
478, p3gpqB_, 0.6349, 3.48, 0.121, 191, 141, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS IN COMPLEX WITH RNA
479, d2acfB2, 0.6347, 3.50, 0.121, 191, 141, NMR STRUCTURE OF SARS-COV NON-STRUCTURAL PROTEIN NSP3A (SARS1) FROM SARS CORONAVIRUS
480, d5lhbA_, 0.6343, 3.49, 0.121, 201, 141, POLYADPRIBOSYL GLYCOSIDASE IN COMPLEX WITH PDD00017262
481, p4eppB_, 0.6343, 3.49, 0.121, 191, 141, CANONICAL POLY(ADP-RIBOSE) GLYCOHYDROLASE FROM TETRAHYMENA THERMOPHILA.
482, d5dusA1, 0.6342, 3.78, 0.105, 507, 143, CRYSTAL STRUCTURE OF MERS-COV MACRO DOMAIN IN COMPLEX WITH ADP-RIBOSE
483, d4n9zA_, 0.6341, 2.82, 0.130, 160, 131, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E749Q
484, d2acfC2, 0.6337, 3.53, 0.135, 201, 141, NMR STRUCTURE OF SARS-COV NON-STRUCTURAL PROTEIN NSP3A (SARS1) FROM SARS CORONAVIRUS
485, p4l2hA_, 0.6335, 3.51, 0.103, 160, 136, STRUCTURE OF A CATALYTICALLY INACTIVE PARG IN COMPLEX WITH A POLY-ADP- RIBOSE FRAGMENT
486, p5nsqF2, 0.6332, 2.91, 0.142, 150, 127, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH ACTINONIN
487, d4na6B_, 0.6331, 2.91, 0.142, 150, 127, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E749N
488, d3ewpA1, 0.6331, 2.98, 0.092, 160, 131, COMPLEX OF SUBSTRATE ADP-RIBOSE WITH IBV NSP3 ADRP DOMAIN
489, d4n9zB_, 0.6326, 2.92, 0.085, 168, 130, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E749Q
490, d4na0C_, 0.6316, 3.92, 0.113, 507, 142, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN WITH ADPRIBOSE
491, d3uekA_, 0.6315, 2.95, 0.107, 155, 131, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF RAT POLY (ADP-RIBOSE) GLYCOHYDROLASE
492, d4na4B_, 0.6312, 3.61, 0.064, 439, 140, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN WITH ADP-HPD
493, d4na0B_, 0.6312, 3.71, 0.107, 505, 140, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN WITH ADPRIBOSE
494, d3ejfA_, 0.6312, 2.95, 0.107, 156, 131, CRYSTAL STRUCTURE OF IBV X-DOMAIN AT PH 8.5
495, d4na4A_, 0.6309, 3.86, 0.113, 521, 142, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN WITH ADP-HPD
496, p3gpgB_, 0.6304, 3.96, 0.112, 506, 143, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS
497, d3ewoA1, 0.6300, 3.87, 0.113, 521, 142, IBV NSP3 ADRP DOMAIN
498, d4n9yA_, 0.6297, 3.96, 0.112, 507, 143, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E748Q
499, d4b1gA_, 0.6297, 3.97, 0.112, 507, 143, STRUCTURE OF UNLIGANDED HUMAN PARG CATALYTIC DOMAIN
500, d4na0A_, 0.6296, 2.96, 0.099, 156, 131, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN WITH ADPRIBOSE
501, d4na4C_, 0.6292, 3.64, 0.064, 439, 140, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN WITH ADP-HPD
502, d4na5A_, 0.6290, 3.64, 0.064, 439, 140, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN MUTANT E748N
503, p4tu0A_, 0.6288, 3.83, 0.113, 521, 141, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS NSP3 MACRO DOMAIN IN COMPLEX WITH A 2 -5  OLIGOADENYLATE TRIMER
504, p3gpgA_, 0.6288, 2.99, 0.099, 160, 131, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS
505, d5holA1, 0.6285, 2.91, 0.132, 172, 129, THE CRYSTAL STRUCTURE OF THE MERS-COV MACRO DOMAIN WITH ADP-RIBOSE
506, d2acfD2, 0.6282, 3.94, 0.113, 507, 142, NMR STRUCTURE OF SARS-COV NON-STRUCTURAL PROTEIN NSP3A (SARS1) FROM SARS CORONAVIRUS
507, p3gpoD_, 0.6278, 3.62, 0.057, 439, 140, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS IN COMPLEX WITH ADP-RIBOSE
508, d3ekeA_, 0.6274, 2.66, 0.097, 164, 124, CRYSTAL STRUCTURE OF IBV X-DOMAIN AT PH 5.6
509, p3gpgC_, 0.6272, 3.77, 0.099, 509, 141, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS
510, p5iq5A_, 0.6268, 2.93, 0.132, 175, 129, NMR SOLUTION STRUCTURE OF MAYARO VIRUS MACRO DOMAIN
511, p3gqeA_, 0.6260, 3.67, 0.057, 436, 140, CRYSTAL STRUCTURE OF MACRO DOMAIN OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS
512, d5hihA1, 0.6258, 3.63, 0.121, 187, 141, CRYSTAL STRUCTURE OF THE MACRO DOMAIN IN MIDDLE-EAST RESPIRATORY SYNDROME CORONAVIRUS
513, p3gpoC_, 0.6257, 3.87, 0.098, 504, 143, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS IN COMPLEX WITH ADP-RIBOSE
514, p3gpoB_, 0.6257, 2.92, 0.100, 174, 130, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS IN COMPLEX WITH ADP-RIBOSE
515, p3gqeB_, 0.6256, 3.77, 0.099, 508, 141, CRYSTAL STRUCTURE OF MACRO DOMAIN OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS
516, d3ewrA_, 0.6255, 3.97, 0.113, 492, 142, COMPLEX OF SUBSTRATE ADP-RIBOSE WITH HCOV-229E NSP3 ADRP DOMAIN
517, p4tu0D_, 0.6254, 3.96, 0.113, 521, 142, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS NSP3 MACRO DOMAIN IN COMPLEX WITH A 2 -5  OLIGOADENYLATE TRIMER
518, p4tu0B_, 0.6254, 3.96, 0.113, 521, 142, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS NSP3 MACRO DOMAIN IN COMPLEX WITH A 2 -5  OLIGOADENYLATE TRIMER
519, p3gpoA_, 0.6247, 4.00, 0.112, 485, 143, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS IN COMPLEX WITH ADP-RIBOSE
520, d4fc2C_, 0.6246, 3.99, 0.112, 493, 143, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN
521, d4fc2B_, 0.6246, 2.90, 0.124, 166, 129, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN
522, p5nthA2, 0.6244, 4.00, 0.112, 496, 143, STRUCTURE OF LEUCYL AMINOPEPTIDASE FROM LEISHMANIA MAJOR IN COMPLEX WITH ACTINONIN
523, d2acfA1, 0.6243, 3.08, 0.092, 162, 131, NMR STRUCTURE OF SARS-COV NON-STRUCTURAL PROTEIN NSP3A (SARS1) FROM SARS CORONAVIRUS
524, d4fc2D_, 0.6242, 3.08, 0.092, 162, 131, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN
525, p3gpgD_, 0.6241, 2.96, 0.092, 174, 130, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS
526, d4fc2A_, 0.6234, 2.96, 0.092, 174, 130, CRYSTAL STRUCTURE OF MOUSE POLY(ADP-RIBOSE) GLYCOHYDROLASE (PARG) CATALYTIC DOMAIN
527, d1txzA_, 0.6233, 4.00, 0.112, 507, 143, CRYSTAL STRUCTURE OF YEAST YMX7 AN ADP-RIBOSE-1  -MONOPHOSPHATASE COMPLEXED WITH ADP-RIBOSE
528, d3ewqA_, 0.6228, 3.78, 0.114, 489, 140, HCOV-229E NSP3 ADRP DOMAIN
529, p4tu0C_, 0.6223, 4.02, 0.112, 492, 143, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS NSP3 MACRO DOMAIN IN COMPLEX WITH A 2 -5  OLIGOADENYLATE TRIMER
530, d1ty8A_, 0.6214, 4.03, 0.112, 496, 143, CRYSTAL STRUCTURE OF YEAST YMX7 AN ADP-RIBOSE-1  -MONOPHOSPHATASE COMPLEXED WITH ADP
531, p5m3iD_, 0.6207, 3.86, 0.113, 505, 141, MACRODOMAIN OF MYCOBACTERIUM TUBERCULOSIS DARG
532, p5m31A_, 0.6203, 3.02, 0.100, 160, 130, MACRODOMAIN OF THERMUS AQUATICUS DARG
533, p5m3iB_, 0.6202, 3.03, 0.100, 160, 130, MACRODOMAIN OF MYCOBACTERIUM TUBERCULOSIS DARG
534, p3jztB_, 0.6202, 2.84, 0.103, 166, 126, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV WITH ADP-RIBOSE
535, p5m3iC_, 0.6201, 2.96, 0.140, 176, 129, MACRODOMAIN OF MYCOBACTERIUM TUBERCULOSIS DARG
536, p5m3iA_, 0.6200, 2.96, 0.140, 176, 129, MACRODOMAIN OF MYCOBACTERIUM TUBERCULOSIS DARG
537, p3jztC_, 0.6191, 2.96, 0.101, 154, 129, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV WITH ADP-RIBOSE
538, d2favB_, 0.6191, 3.01, 0.100, 171, 130, CRYSTAL STRUCTURE OF SARS MACRO DOMAIN IN COMPLEX WITH ADP- RIBOSE AT 1.8 A RESOLUTION
539, d2favA_, 0.6188, 3.06, 0.092, 159, 130, CRYSTAL STRUCTURE OF SARS MACRO DOMAIN IN COMPLEX WITH ADP- RIBOSE AT 1.8 A RESOLUTION
540, p3etiE_, 0.6187, 3.14, 0.115, 159, 131, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV
541, p3etiH_, 0.6185, 3.12, 0.123, 162, 130, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV
542, p3jztD_, 0.6180, 2.84, 0.096, 166, 125, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV WITH ADP-RIBOSE
543, p3jztE_, 0.6179, 2.84, 0.096, 166, 125, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV WITH ADP-RIBOSE
544, p3ew5C_, 0.6176, 3.00, 0.101, 156, 129, STRUCTURE OF THE TETRAGONAL CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV
545, p3etiG_, 0.6175, 2.99, 0.101, 156, 129, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV
546, p3etiA_, 0.6175, 3.09, 0.123, 158, 130, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV
547, p3ew5B_, 0.6174, 2.89, 0.086, 167, 128, STRUCTURE OF THE TETRAGONAL CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV
548, p3etiD_, 0.6170, 2.99, 0.101, 157, 129, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV
549, d2favC_, 0.6169, 3.08, 0.092, 161, 130, CRYSTAL STRUCTURE OF SARS MACRO DOMAIN IN COMPLEX WITH ADP- RIBOSE AT 1.8 A RESOLUTION
550, p5m3eA_, 0.6167, 3.01, 0.101, 158, 129, MACRODOMAIN OF THERMUS AQUATICUS DARG IN COMPLEX WITH ADP-RIBOSE
551, p3jztH_, 0.6166, 4.07, 0.112, 499, 143, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV WITH ADP-RIBOSE
552, p3etiC_, 0.6165, 4.07, 0.112, 498, 143, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV
553, p3ew5A_, 0.6162, 3.67, 0.128, 192, 141, STRUCTURE OF THE TETRAGONAL CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV
554, p3jztA_, 0.6161, 3.67, 0.128, 192, 141, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV WITH ADP-RIBOSE
555, p3etiB_, 0.6158, 3.10, 0.134, 169, 127, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV
556, p3etiF_, 0.6154, 4.09, 0.105, 499, 143, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV
557, d3ejgA_, 0.6146, 3.01, 0.101, 157, 129, CRYSTAL STRUCTURE OF HCOV-229E X-DOMAIN
558, d2vriA_, 0.6089, 4.08, 0.112, 499, 143, STRUCTURE OF THE NSP3 X-DOMAIN OF HUMAN CORONAVIRUS NL63
559, p3gpqD_, 0.6071, 3.58, 0.092, 249, 131, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS IN COMPLEX WITH RNA
560, d1njrA_, 0.6065, 3.58, 0.092, 249, 131, CRYSTAL STRUCTURE OF YEAST YMX7 AN ADP-RIBOSE-1  -MONOPHOSPHATASE
561, p5isnA_, 0.6022, 2.88, 0.087, 167, 127, NMR SOLUTION STRUCTURE OF MACRO DOMAIN FROM VENEZUELAN EQUINE ENCEPHALITIS VIRUS
562, d5e3bA_, 0.5977, 3.05, 0.093, 157, 129, STRUCTURE OF MACRODOMAIN PROTEIN FROM STREPTOMYCES COELICOLOR
563, p2l8rA_, 0.5950, 3.60, 0.092, 249, 131, SOLUTION STRUCTURE OF HUMAN PROTEIN C6ORF130 IN COMPLEX WITH ADP- RIBOSE
564, p4j5rA_, 0.5949, 2.86, 0.167, 152, 126, TARG1 (C6ORF130) TERMINAL ADP-RIBOSE GLYCOHYDROLASE 1 BOUND TO ADP- HPD
565, p2eeeA_, 0.5930, 2.88, 0.120, 151, 125, SOLUTION STRUCTURE OF THE A1PP DOMAIN FROM HUMAN PROTEIN C6ORF130
566, p2lgrA_, 0.5929, 2.86, 0.167, 152, 126, SOLUTION STRUCTURE OF HUMAN PROTEIN C6ORF130 A PUTATIVE MACRO DOMAIN
567, p2hc9A1, 0.5922, 3.09, 0.100, 168, 130, STRUCTURE OF CAENORHABDITIS ELEGANS LEUCINE AMINOPEPTIDASE-ZINC COMPLEX (LAP1)
568, p4j5sB_, 0.5921, 2.87, 0.167, 152, 126, TARG1 (C6ORF130) TERMINAL ADP-RIBOSE GLYCOHYDROLASE 1 ADP-RIBOSE COMPLEX
569, p2hb6A1, 0.5919, 2.86, 0.167, 152, 126, STRUCTURE OF CAENORHABDITIS ELEGANS LEUCINE AMINOPEPTIDASE (LAP1)
570, p2hb6B1, 0.5917, 3.10, 0.100, 168, 130, STRUCTURE OF CAENORHABDITIS ELEGANS LEUCINE AMINOPEPTIDASE (LAP1)
571, p4j5sD_, 0.5908, 2.96, 0.128, 168, 125, TARG1 (C6ORF130) TERMINAL ADP-RIBOSE GLYCOHYDROLASE 1 ADP-RIBOSE COMPLEX
572, p4j5qA_, 0.5908, 3.17, 0.118, 169, 127, TARG1 (C6ORF130) TERMINAL ADP-RIBOSE GLYCOHYDROLASE 1 APO STRUCTURE
573, p4j5sA_, 0.5907, 3.03, 0.101, 168, 129, TARG1 (C6ORF130) TERMINAL ADP-RIBOSE GLYCOHYDROLASE 1 ADP-RIBOSE COMPLEX
574, p4j5sC_, 0.5901, 3.04, 0.093, 168, 129, TARG1 (C6ORF130) TERMINAL ADP-RIBOSE GLYCOHYDROLASE 1 ADP-RIBOSE COMPLEX
575, p4j5rB_, 0.5893, 3.16, 0.092, 168, 131, TARG1 (C6ORF130) TERMINAL ADP-RIBOSE GLYCOHYDROLASE 1 BOUND TO ADP- HPD
576, d2fg1A2, 0.5891, 3.04, 0.109, 168, 129, STRUCTURE OF A PROTEIN OF UNKNOWN FUNCTION FROM BACTEROIDES THETAIOTAOMICRON.
577, d2afcA1, 0.5889, 3.03, 0.092, 168, 130, X-RAY CRYSTAL STRUCTURE OF PROTEIN Q8A8B0 FROM BACTEROIDES THETAIOTAOMICRON. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BTR9.
578, d2afcB_, 0.5881, 3.04, 0.093, 168, 129, X-RAY CRYSTAL STRUCTURE OF PROTEIN Q8A8B0 FROM BACTEROIDES THETAIOTAOMICRON. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BTR9.
579, p3gpqC_, 0.5877, 3.04, 0.093, 168, 129, CRYSTAL STRUCTURE OF MACRO DOMAIN OF CHIKUNGUNYA VIRUS IN COMPLEX WITH RNA
580, p3jztF_, 0.5791, 3.04, 0.093, 168, 129, STRUCTURE OF A CUBIC CRYSTAL FORM OF X (ADRP) DOMAIN FROM FCOV WITH ADP-RIBOSE
581, p3ij3A1, 0.5612, 3.20, 0.115, 166, 131, 1.8 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF CYTOSOL AMINOPEPTIDASE FROM COXIELLA BURNETII
582, p2w2gB1, 0.5322, 3.05, 0.093, 168, 129, HUMAN SARS CORONAVIRUS UNIQUE DOMAIN
583, p2wctD1, 0.5286, 3.02, 0.128, 168, 125, HUMAN SARS CORONAVIRUS UNIQUE DOMAIN (TRICLINIC FORM)
584, p2wctC1, 0.5286, 2.96, 0.119, 152, 126, HUMAN SARS CORONAVIRUS UNIQUE DOMAIN (TRICLINIC FORM)
585, p2w2gA1, 0.5279, 2.96, 0.119, 152, 126, HUMAN SARS CORONAVIRUS UNIQUE DOMAIN
586, p2wctA1, 0.5276, 3.05, 0.109, 168, 129, HUMAN SARS CORONAVIRUS UNIQUE DOMAIN (TRICLINIC FORM)
587, p2wctB1, 0.5275, 3.06, 0.093, 168, 129, HUMAN SARS CORONAVIRUS UNIQUE DOMAIN (TRICLINIC FORM)
